MedPlus Subsidiary Faces Drug License Suspensions
⚠️ MEDPLUS informed that its subsidiary, Optival Health Solutions, has received six drug license suspension orders across select stores in Karnataka and Telangana, which may result in a potential revenue impact of approximately ₹6.98 lakh, as per the company’s latest disclosure.
#FundamentalViews#WatchOutFor
1,149 likes·61 comments

















